This vaccine is a new tool in EPM disease prevention management, and offers horse owners an economic alternative to lengthy and very costly treatment programs. Efficacy and potency test studies are in progress with the goal being to satisfy the requirements for full licensure.
Stringent criteria exist for conditional licensing as well as for the full federal licensing.
For the ease of the reader this S. neurona vaccine will be referred to in this manuscript as EPM vaccine. This review includes a summary of the objective data FDAH has submitted to the USDA to support the conditional licensing of this vaccine. This guide was developed to give veterinarians a quick overview of EPM disease and its ramifications. The ultimate objective of this guide is to offer you information that is available concerning the development and introduction of S. neurona vaccine. As you read on, this guide will provide answers that will allow you to decide how to use this new tool in your practice.